1133820-07-1

Basic information

• Product Name: 5-{4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione
• Synonyms: 5-{4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione
• CAS NO: 1133820-07-1
• Molecular Weight: 361.394
• Mol File: 1133820-07-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 5-{4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 5-{4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione(1133820-07-1)
• EPA Substance Registry System: 5-{4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione(1133820-07-1)

Safety Data

• Hazardous Substances Data: 1133820-07-1(Hazardous Substances Data)

Upstream product

• 1133820-05-9 4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzaldehyde 
• 350-51-6 3-fluorostyrene 
• 18511-63-2 3-fluorophenylethylene oxide 
• 1133820-06-0 5-{4-[2-(3-fluorophenyl)-2-hydroxyethoxy]benzylidene}-1,3-thiazolidine-2,4-dione 

Downstream Products

• 1133819-86-9 5-{4-[2-(3-fluorophenyl)-2-oxoethoxy]benzyl}-1,3-thiazolidine-2,4-dione 

Relevant articles and documents

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).

THIAZOLIDINEDIONE ANALOGUES

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. In other aspects, the present invention also presents methods of treating hypertension, diabetes, or other inflamm